Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Teva Pharmaceutical Industries Limited

TEVA•NYSE
Healthcare
Drug Manufacturers - Specialty & Generic
$34.33
$0.11(0.32%)
U.S. Market opens in 13h 38m

Teva Pharmaceutical Industries Limited (TEVA) Stock Overview

Explore Teva Pharmaceutical Industries Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap38.9B
P/E Ratio27.59
EPS (TTM)$1.21
ROE0.20%
Fundamental Analysis

AI Price Forecasts

1 Month$33.40
3 Months$39.48
1 Year Target$32.04

TEVA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Teva Pharmaceutical Industries Limited (TEVA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 54.40, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $32.04.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 27.59 and a market capitalization of 38.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-0.89%
5-Day Change
-0.83%
1-Month Change
6.62%
3-Month Change
40.09%
6-Month Change
83.72%
Year-to-Date (YTD) Change
9.58%
1-Year Change
102.12%
3-Year Change
238.81%
5-Year Change
219.65%
All-Time (Max) Change
3642.34%

Contact Information

https://www.tevapharm.com
972 3 914 8213
124 Dvora Hanevi'a Street, Tel Aviv, NaN, 6944020

Company Facts

370,000 Employees
IPO DateFeb 16, 1982
CountryIL
Actively Trading

Frequently Asked Questions